Is it safe?
Can IDXX take a bad year?
Idexx Laboratories carries $622M of net debt at 0.39× EBITDA: a load its earnings can carry.
$622M
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 0.39×
Net debt / EBITDA · 0.62× a year ago · the load is coming down
- Altman Z-score
- 20.43
Altman Z-score · safe zone, above 3
- Interest cover
- 38.6×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ2 2026
- $819M
- Cash and short-term investments
- $197M
- Net debt
- $622M
- EBITDA, trailing twelve months
- $1.61B
- Operating profit, trailing twelve months
- $1.46B
- Debt / equity
- 0.51×
- Total debt / EBITDA
- 0.51×
- Annualised volatilitytwo years of daily moves
- 38%
- Worst drawdown on file
- −54%
- Below its 52-week high
- −28%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Diagnostics & Research
Ranks #10 of 29 by Smart Score